SCHEMBL6858136

SCHEMBL6858136

Cc1ccc(-c2ccc3ccccc3n2)c(C)c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 9/20 0.52
▸ CYP1A2 P05177 3/20 0.47
▸ NPC1 O15118 8/20 0.46
▸ RAB9A P51151 8/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ POLB P06746 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ ALDH1A1 P00352 5/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ MAPT P10636 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986356 0.86 AR (0.59) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL29986008 0.84 AR (0.57) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL9641658 0.82 AR (0.55) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL4788772 0.79 AR (0.64) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL29986262 0.79 AR (0.64) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL6859684 0.78 AR (0.62) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL12319823 0.77 AR (0.57) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL18774770 0.77 AR (0.57) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL16310381 0.76 AR (0.59) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL12447362 0.75 AR (0.59) ARCYP1A2NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100357302-C Phosphorescent compound and element comprising same UNIVERSAL DISPLAY CORP (US) 2007-12-26 — — CN disclosed
CN-1589307-A Phosphorescent compounds and devices comprising the same UNIVERSAL DISPLAY CORP (US) 2005-03-02 — — CN disclosed
US-6835469-B2 Phosphorescent compounds and devices comprising the same THE UNIVERSITY OF SOUTHERN CALIFORNIA 2004-12-28 — — US disclosed
WO-2003033617-A1 PHOSPHORESCENT COMPOUNDS AND DEVICES COMPRISING THE SAME UNIVERSAL DISPLAY CORPORATION (US) 2003-04-24 — — WO disclosed
US-20030072964-A1 Phosphorescent compounds and devices comprising the same TRUSTEES OF PRINCETON UNIVERSITY, THE 2003-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030072964-A1 Phosphorescent compounds and devices comprising the same NUDC, ORC3, PAICS AR 3237/4885CYP1A2 4061/4885NPC1 3932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback